Novo Nordisk shares dip as Wegovy maker posts earnings miss, cuts operating profit outlook

📆 2024-08-07 10:51:00
📰 NBCPhiladelphia

⏱ Reading Time:
23 sec. here
2 min. at publisher
📊 Quality Score:
News: 13%
Publisher: 51%

News Nyheter

Sverige Senaste nytt,Sverige Rubriker

Novo Nordisk on Wednesday announced its second quarter earnings for 2024.

Novo Nordisk on Wednesday said its net profit came in at 20.05 billion Danish kroner in the second quarter of 2024, below forecasts.

EBIT — earnings before interest and tax — came in at 25.93 billion Danish kroner in the second quarter, which was also below the LSEG forecast of 26.86 billion Danish kroner.saying growth was now anticipated to come in between 20% and 28%, rather than the previously expected 22% to 30% range. Sales of popular weight loss drug Wegovy jumped 55% in the second quarter of 2024, compared to the same period in 2023, coming in at 11.66 billion kroner.

Skriv Kommentar

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Källa: NBCLA - 🏆 319. / 59 Läs mer »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Källa: CNBC - 🏆 12. / 72 Läs mer »

Shares of Wegovy maker Novo Nordisk slide 5% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Källa: NBCNewYork - 🏆 270. / 63 Läs mer »

Shares of Wegovy maker Novo Nordisk slide 7% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Källa: CNBC - 🏆 12. / 72 Läs mer »